WO2003076561A3 - Proteine de fusion a recombinase presentant un apport cellulaire ameliore - Google Patents

Proteine de fusion a recombinase presentant un apport cellulaire ameliore Download PDF

Info

Publication number
WO2003076561A3
WO2003076561A3 PCT/EP2003/002280 EP0302280W WO03076561A3 WO 2003076561 A3 WO2003076561 A3 WO 2003076561A3 EP 0302280 W EP0302280 W EP 0302280W WO 03076561 A3 WO03076561 A3 WO 03076561A3
Authority
WO
WIPO (PCT)
Prior art keywords
fusion protein
recombinase
cellular uptake
domain
protein
Prior art date
Application number
PCT/EP2003/002280
Other languages
English (en)
Other versions
WO2003076561A2 (fr
Inventor
Frank Oliver Stefan Edenhofer
Michael Peitz
Kurt Pfannkuche
Klaus Rajewski
Original Assignee
Artemis Pharmaceuticals Gmbh
Frank Oliver Stefan Edenhofer
Michael Peitz
Kurt Pfannkuche
Klaus Rajewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02005468A external-priority patent/EP1342781A1/fr
Application filed by Artemis Pharmaceuticals Gmbh, Frank Oliver Stefan Edenhofer, Michael Peitz, Kurt Pfannkuche, Klaus Rajewski filed Critical Artemis Pharmaceuticals Gmbh
Priority to AU2003210422A priority Critical patent/AU2003210422A1/en
Publication of WO2003076561A2 publication Critical patent/WO2003076561A2/fr
Publication of WO2003076561A3 publication Critical patent/WO2003076561A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne une protéine de fusion comprenant un domaine de recombinaison d'ADN spécifique à un site, tel que la Cre recombinase, et un domaine contenant un signal de localisation nucléaire modifié spécifique. La protéine de fusion peut également comprendre un domaine de transduction de protéine tel que le FGF hydrophobe et le peptide TAT basique. Le signal de localisation nucléaire spécifique seul ou avec le domaine de transduction de protéine favorise l'apport cellulaire de la recombinase. La protéine de fusion est un outil essentiel dans le génie génétique des génomes mammifères. L'invention concerne également des séquences d'ADN codant pour ladite protéine de fusion, des méthodes de production de ladite protéine de fusion, et son utilisation en tant qu'agent d'induction du ciblage d'un gène chez un organisme vivant ou dans des cellules en culture.
PCT/EP2003/002280 2002-03-09 2003-03-06 Proteine de fusion a recombinase presentant un apport cellulaire ameliore WO2003076561A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003210422A AU2003210422A1 (en) 2002-03-09 2003-03-06 Recombinase fusion protein with enhanced cellular uptake

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02005468.0 2002-03-09
EP02005468A EP1342781A1 (fr) 2002-03-09 2002-03-09 Protéine de fusion de recombinase avec une assimilation cellulaire accrue
US36379702P 2002-03-13 2002-03-13
US60/363,797 2002-03-13

Publications (2)

Publication Number Publication Date
WO2003076561A2 WO2003076561A2 (fr) 2003-09-18
WO2003076561A3 true WO2003076561A3 (fr) 2004-01-22

Family

ID=27806514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/002280 WO2003076561A2 (fr) 2002-03-09 2003-03-06 Proteine de fusion a recombinase presentant un apport cellulaire ameliore

Country Status (2)

Country Link
AU (1) AU2003210422A1 (fr)
WO (1) WO2003076561A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927691B2 (en) 2003-10-24 2015-01-06 Gencia Corporation Transducible polypeptides for modifying metabolism
US8952133B2 (en) 2003-10-24 2015-02-10 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissue

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2530248A1 (fr) * 2003-06-25 2005-01-06 Gencia Corporation Vecteurs modifies pour la transfection d'organite
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
JPWO2007132555A1 (ja) * 2006-05-11 2009-09-24 国立大学法人 東京大学 細胞膜透過性ペプチドと細胞内におけるその使用
WO2008109010A1 (fr) 2007-03-02 2008-09-12 Arbor Vita Corporation Traitement des incidents cérébrovasculaires et d'autres maladies sans inhibition des canaux calcium de type n
JP5709013B2 (ja) 2009-04-10 2015-04-30 東亞合成株式会社 神経分化誘導ペプチド及びその利用
WO2011013700A1 (fr) 2009-07-29 2011-02-03 東亞合成株式会社 Fragment peptidique de support et son utilisation
WO2011013698A1 (fr) 2009-07-29 2011-02-03 東亞合成株式会社 Fragment peptidique support et son utilisation
JP5792625B2 (ja) 2009-11-02 2015-10-14 東亞合成株式会社 細胞増殖促進ペプチド及びその利用
WO2011152524A1 (fr) 2010-06-04 2011-12-08 東亞合成株式会社 Peptide favorisant la croissance cellulaire et son utilisation
US9238796B2 (en) 2010-06-04 2016-01-19 Toagosei Co. Ltd. Cell growth-promoting peptide and use thereof
JP6066222B2 (ja) 2012-05-28 2017-01-25 東亞合成株式会社 抗菌ペプチド及びその利用
WO2014061749A1 (fr) 2012-10-18 2014-04-24 東亞合成株式会社 Peptide synthétique capable de supprimer l'expression du récepteur du tnf de type 2, et son utilisation
US9943611B2 (en) * 2012-11-01 2018-04-17 California Institute Of Technology Reversible gene expression
JP6425161B2 (ja) * 2014-04-30 2018-11-21 国立大学法人名古屋大学 投射経路選択的な遺伝子発現制御
EP3334756B1 (fr) * 2015-08-10 2020-06-17 Cellivery Therapeutics, Inc. Protéine recombinée cre à perméabilité cellulaire améliorée (icp-cre) et son utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001086989A (ja) * 1999-09-17 2001-04-03 Univ Osaka 哺乳類型Ｃｒｅリコンビナーゼ遺伝子
WO2001049832A2 (fr) * 2000-01-07 2001-07-12 Artemis Pharmaceuticals Gmbh Transduction de recombinases pour ciblage genetique inductible

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001086989A (ja) * 1999-09-17 2001-04-03 Univ Osaka 哺乳類型Ｃｒｅリコンビナーゼ遺伝子
GB2355718A (en) * 1999-09-17 2001-05-02 Osaka University The President Modified cre recombinase gene
WO2001049832A2 (fr) * 2000-01-07 2001-07-12 Artemis Pharmaceuticals Gmbh Transduction de recombinases pour ciblage genetique inductible

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 23 August 2001 (2001-08-23), UNIV OSAKA: "Mammalian Cre recombinase", XP002200325, Database accession no. AAB98695 *
HODEL ET AL.: "Dissection of a Nuclear Localization Signal", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 2, 12 January 2001 (2001-01-12), pages 1317 - 1325, XP002200324 *
JO ET AL.: "Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase", NATURE BIOTECHNOLOGY, vol. 19, October 2001 (2001-10-01), pages 929 - 933, XP002200323 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927691B2 (en) 2003-10-24 2015-01-06 Gencia Corporation Transducible polypeptides for modifying metabolism
US8952133B2 (en) 2003-10-24 2015-02-10 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissue

Also Published As

Publication number Publication date
WO2003076561A2 (fr) 2003-09-18
AU2003210422A8 (en) 2003-09-22
AU2003210422A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
WO2003076561A3 (fr) Proteine de fusion a recombinase presentant un apport cellulaire ameliore
DE69935857D1 (de) Expression eukarotischer peptide in pflanzenplastiden
CN106795521A (zh) 用于修饰所靶向基因座的方法和组合物
NZ504214A (en) Recombination cloning using nucleic acids having recombination sites
PL352332A1 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
WO2002016583A3 (fr) Nouveaux produits de recombinaison et leur utilisation dans des mecanismes d'action metaboliques.
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
GB2367555A (en) Control of gene expression
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
WO2004042010A3 (fr) Acides nucleiques modifies de la luciferase et procedes d'utilisation
AU8491401A (en) Phage-dependent superproduction of biologically active protein and peptides
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO2005034876A3 (fr) Utilisation de lignees cellulaires pour produire des proteines therapeutiques actives
WO2001049832A3 (fr) Transduction de recombinases pour ciblage genetique inductible
WO2001000854A3 (fr) Proteines chimeres induisant l'apoptose ciblee
DE69730967D1 (en) Human dnase ii
AU5049100A (en) Phage-dependent super-production of biologically active protein and peptides
WO2001036478A3 (fr) Methodes et compositions se rapportant a des polypeptides et a des polynucleotides similaires au facteur bactericide augmentant la permeabilite
HK1055444A1 (en) Mutant muscle-specific enhancers
WO2003060092A3 (fr) Proteines et genes de l'hydroxylase d'acides gras modifiee
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
DE602004029158D1 (en) Archäen-expressionssystem
DE60310708D1 (de) In vivo stabilsierung von plasmiden

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP